Bronchodilator Agents: all 1,999 studies that test it

Page 5 of 20. Open to participants first (185), then studies with results posted, then the rest; newest registration first within each.

• Tiotropium+Olodaterol Fixed Dose Combination (FDC) in Chronic Obstructive Pulmonary Disease (OTEMTO 2)CompletedNCT02006732Phase 3Results posted
• The Effects Of Bronchodilator Therapy On Respiratory And Autonomic Function In Patients With Familial DysautonomiaCompletedNCT01987219Phase 3Results posted
• Safety, Tolerability and Activity Study of Ibudilast in Subjects With Progressive Multiple SclerosisCompletedNCT01982942Phase 2Results posted
• Characterization of Lung Function Profile of Inhaled Tiotropium + Olodaterol Fixed Dose Combination Compared to Fluticasone Propionate + Salmeterol Fixed Dose Combination in COPD PatientsCompletedNCT01969721Phase 3Results posted
• Tiotropium + Olodaterol Fixed Dose Combination (FDC) in Chronic Obstructive Pulmonary Disease (OTEMTO 1)CompletedNCT01964352Phase 3Results posted
• Effect of Glycopyrronium on Morning Symptoms and Pulmonary Function in Patients With Moderate to Severe COPDCompletedNCT01959516Phase 4Results posted
• Study Evaluating the Effect of Fluticasone Furoate/ Vilanterol (FF/VI) Inhalation Powder Compared With Vilanterol (VI) Inhalation Powder on Bone Mineral Density (BMD) in Subjects With Chronic Obstructive Pulmonary Disease (COPD).CompletedNCT01957150Phase 4Results posted
• Buparid/PARI SINUS Versus Budes® Nasal Spray in the Therapy of Chronic RhinosinusitisCompletedNCT01955980Phase 1/2Results posted
• Buparid/PARI SINUS Versus Budes® Nasal Spray in the Therapy of Chronic Rhinosinusitis With Polyposis NasiCompletedNCT01946711Phase 1/2Results posted
• Ipratropium Bromide in Peri-Operative COPDCompletedNCT01943552Phase 4Results posted
• Safety and Efficacy of Clenbuterol in Individuals With Late-onset Pompe Disease and Receiving Enzyme Replacement TherapyCompletedNCT01942590Phase 1/2Results posted
• Nitric Oxide to Treat Pulmonary EmbolismCompletedNCT01939301Phase 2Results posted
• Efficacy of NVA237 Compared to Tiotropium in Patients With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT01922271Phase 4Results posted
• Efficacy of Fixed Combination of Beclometasone + Formoterol + Glycopyrrolate Versus Foster® in COPDCompletedNCT01917331Phase 3Results posted
• A Randomized, Open-label, Comparative Study to Evaluate an Intermittent Dosing Regimen of Fluticasone Propionate 0.05% Cream (Twice Per Week) in Reducing the Risk of Relapse When Added to Regular Daily Moisturization Using PHYSIOGEL Lotion in Paediatric Subjects With Stabilized Atopic DermatitisCompletedNCT01915914Phase 4Results posted
• Safety and Efficacy Trial of Dymista Nasal Spray in Children Ages 4 to 11 With Seasonal Allergic Rhinitis (SAR)CompletedNCT01915823Phase 3Results posted
• Study of Aclidinium Bromide/Formoterol Fumarate Compared With Salmeterol/Fluticasone Propionate in Patients With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT01908140Phase 3Results posted
• Dose-Response of Salmeterol in ChildrenCompletedNCT01907334Phase 4Results posted
• Drug Combination on Exercise Performance at High AltitudeCompletedNCT01902758Phase 2/3Results posted
• Efficacy and Safety Comparison of Albuterol Spiromax® and ProAir® Hydrofluoroalkane (HFA) in Pediatric PatientsCompletedNCT01899144Phase 2Results posted
• Safety and Efficacy of Albuterol in Individuals With Late-onset Pompe DiseaseCompletedNCT01885936Phase 1/2Results posted
• Inhaled Steroids at Discharge After Emergency Department Visits for Children With Uncontrolled AsthmaTerminatedNCT01881412Not applicableResults posted
• Utilizing Exhaled Breathe Condensate Collection to Study Ion Regulation in Cystic FibrosisCompletedNCT01880723Not applicableResults posted
• Trial of Ibudilast for Methamphetamine DependenceCompletedNCT01860807Phase 2Results posted
• Open-Label Assessment of the Albuterol Spiromax® Dry Powder Inhaler (DPI)CompletedNCT01857323Phase 3Results posted
• Multi-Center Study to Assess the Efficacy and Safety of PT003, PT005, and PT001 in Subjects With Moderate to Very Severe COPD (PINNACLE 2)CompletedNCT01854658Phase 3Results posted
• Study of Safety of Foradil in Patients With Persistent AsthmaTerminatedNCT01845025Phase 4Results posted
• A Study to Assess the Effect of QAW039 in Non-atopic Asthmatic PatientsCompletedNCT01836471Phase 2Results posted
• Control of Tourniquet Pain With an Axillary Ring of Subcutaneous Local AnestheticCompletedNCT01829399Phase 4Results posted
• Eosinophilic Esophagitis Clinical Therapy Comparison TrialTerminatedNCT01821898Phase 2Results posted
• Heart Rate Response to Atropine Doses Less Than 0.1mg IV to Anesthetized InfantsCompletedNCT01819064Phase 4Results posted
• Assessment of Fluticasone Propionate on Ocular Allergy SymptomsCompletedNCT01817790Phase 3Results posted
• To Investigate the Effects of Altering the Time of Day of Dosing (Morning or Evening) With Fluticasone Furoate 100 Micrograms Once Daily Administered Via a Dry Powder Inhaler in Subjects With AsthmaCompletedNCT01808339Phase 2Results posted
• A 1-year Multi-center, Prospective, Cohort Study in Patients With Chronic Obstructive Pulmonary Disease Treated With Long-acting BronchodilatorCompletedNCT01794780Phase 4Results posted
• 3 Month Safety Study of Dymista Nasal Spray and Fluticasone Propionate in Children 4-11 Years of Age With Allergic RhinitisCompletedNCT01794741Phase 3Results posted
• Efficacy of Albuterol SPIROMAX® in Adult and Adolescent Patients With Exercise-Induced Bronchoconstriction (EIB)CompletedNCT01791972Phase 3Results posted
• Effect of Symbicort ® on GR in Sputum in COPDCompletedNCT01787097Phase 4Results posted
• LIPS-B: Lung Injury Prevention Study With Budesonide and BetaCompletedNCT01783821Phase 2Results posted
• Dose Ranging Study of the Salmeterol Component of Fluticasone /Salmeterol Spiromax Compared to Fluticasone Spiromax and Advair Diskus in Asthma SubjectsCompletedNCT01772368Phase 2Results posted
• Evaluating the Control of COPD Symptoms in Patients Treated With Tiotropium Bromide 18mcg Once Daily Alone, ADOAIR 50/250mcg Twice Daily Alone or ADOAIR 50/250mcg Plus Tiotropium Bromide 18mcgCompletedNCT01762800Phase 4Results posted
• Changes in Cardiac Function in COPD Patients After Administration of Budesonide/Formoterol (Symbicort®) Versus PlaceboTerminatedNCT01760304Phase 4Results posted
• Perioperative Aminophylline to Improve Early Kidney Function After a Kidney TransplantCompletedNCT01759862Not applicableResults posted
• Femoral Nerve Block for Femur Fracture Repair in PediatricsTerminatedNCT01759407Phase 2Results posted
• A 3 Way Cross-over Study Evaluating the Effects of ADOAIR Twice Daily Plus Tiotropium Bromide Once Daily Compared With the Individual Treatments of Japanese SubjectsCompletedNCT01751113Phase 4Results posted
• Management of Recurrent CroupTerminatedNCT01748162Phase 3Results posted
• Study of Inhaled Nitric Oxide (iNO) and Respiratory Outcomes in Late Preterm InfantsTerminatedNCT01748045Phase 2/3Results posted
• Inhaler Lung Deposition in Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT01721291Phase 4Results posted
• Inhaled Nitric Oxide and Inhaled Prostacyclin After Cardiac Surgery for Heart Transplant or LVAD PlacementCompletedNCT01717209Phase 4Results posted
• Comparison of Topical Vasoconstriction in Endoscopic Sinus SurgeryCompletedNCT01706952Phase 4Results posted
• An Effectiveness Study Comparing Fluticasone Furoate (FF, GW685698)/Vilanterol (VI, GW642444) With Standard Treatment in AsthmaCompletedNCT01706198Phase 3Results posted
• A Study to Characterize Pharmacokinetics of Tiotropium + Olodaterol Fixed-dose Combination in Japanese Patients With COPD.CompletedNCT01703845Phase 1Results posted
• Rapid Acclimatization to Hypoxia at AltitudeCompletedNCT01702025Phase 1/2Results posted
• Safety Study of Albuterol Spiromax® in Subjects With AsthmaCompletedNCT01698320Phase 3Results posted
• Comparison of Two Daily Dose Regimens of Tiotropium 5 µg Once Daily and Tiotropium 2.5 µg Twice Daily for 4 Weeks on Top of Maintenance Therapy With Inhaled Corticosteroid Controller MedicationCompletedNCT01696071Phase 2Results posted
• Co-administration of Olodaterol Respimat® and Tiotropium Handihaler®CompletedNCT01696058Phase 3Results posted
• Co-administration of Olodaterol Respimat® and Tiotropium Handihaler®CompletedNCT01694771Phase 3Results posted
• RELOVAIR® Lung Deflation StudyCompletedNCT01691885Phase 3Results posted
• A Study to Look at Day to Day Changes in Lung Function in COPD Subjects Taking Albuterol/Salbutamol and IpratropiumCompletedNCT01691482Phase 4Results posted
• Effectiveness of Ipratropium Bromide in Preventing Exercise-induced Bronchoconstriction in AthletesCompletedNCT01691079Phase 4Results posted
• An Efficacy and Safety Study of Fluticasone Furoate/Vilanterol (FF/VI) 200/25 Microgram (mcg) , FF/VI 100/25 mcg, and FF 100 mcg in Adults and Adolescents With Persistent Asthma.CompletedNCT01686633Phase 3Results posted
• Investigate the Impact of Early Treatment Initiation With Tiotropium in Patients Recovering From Hospitalization for an Acute COPD Exacerbation 1CompletedNCT01663987Phase 4Results posted
• Investigate the Impact of Early Treatment Initiation With Tiotropium in Patients Recovering From Hospitalization for an Acute COPD Exacerbation 2CompletedNCT01662986Phase 4Results posted
• Assessment of Health-status of Patients With Chronic Obstructive Pulmonary Disease (COPD) on Maintenance Therapy With Spiriva HH Measured by COPD Assessment Test (CAT) TestCompletedNCT01644734Phase 4Results posted
• OBS in Adolescent and Adults With EOE: A Phase II, Randomized, Double-Blind, Placebo Controlled, Study With an Open Label ExtensionCompletedNCT01642212Phase 2Results posted
• A 3-period Crossover Study With GSK573719 as Monotherapy in Adult Subjects With AsthmaCompletedNCT01641692Phase 2Results posted
• Efficacy and Safety Study to Compare Formoterol Fumerate in the Pressair DPI to the Foradil Aerolizer in Patient With Mild to Moderate AsthmaCompletedNCT01641081Phase 2Results posted
• Evaluation of Tiotropium 2.5 and 5 mcg Once Daily Delivered Via the Respimat® Inhaler Compared to Placebo in 1 to 5 Year Old Patients With Persistent AsthmaCompletedNCT01634113Phase 2Results posted
• Study FFR116364, a Placebo-controlled Study of GW685698X in Paediatric Subjects With Perennial Allergic RhinitisCompletedNCT01630135Phase 3Results posted
• Efficacy and Safety Study of Intranasal Administration of 100, 200, and 400 μg of Fluticasone Propionate Using a Novel Bi-directional DeviceCompletedNCT01624662Phase 3Results posted
• Study Evaluating the Safety of Intranasal Administration of 400 μg of Fluticasone Propionate Twice a Day (BID) Using a Novel Bi-Directional Device in Subjects With Chronic Sinusitis With or Without Nasal PolypsCompletedNCT01623323Phase 3Results posted
• 12-Month OL Intranasal Fluticasone Propionate BID Using OptiNose DeviceCompletedNCT01623310Phase 3Results posted
• Study Evaluating the Efficacy and Safety of Intranasal Administration of 100, 200, and 400 μg of Fluticasone Propionate Twice a Day (BID) Using a Novel Bi Directional Device in Subjects With Bilateral Nasal Polyposis Followed by an 8-Week Open-Label Extension Phase to Assess SafetyCompletedNCT01622569Phase 3Results posted
• Study FFR116365, an Open-label Study of GW685698X in Paediatric Subjects With Perennial Allergic RhinitisCompletedNCT01622231Phase 3Results posted
• Drug Interaction Study of Colchicine and TheophyllineCompletedNCT01601132Phase 4Results posted
• Safety Evaluation of Aminophylline and MethazolamideCompletedNCT01587027Phase 1Results posted
• Voiding Function After Mid-Urethral Slings With and Without Local Anesthetic: Randomized Controlled TrialCompletedNCT01583166Not applicableResults posted
• Bepotastine Besilate-corticosteroid Nasal Spray Combination Compared to Placebo, Bepotastine Besilate Nasal Spray, and Corticosteroid Nasal Spray in the Treatment of Patients With Seasonal Allergic RhinitisCompletedNCT01578278Phase 2Results posted
• A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler (Puffer) in Adolescents and Adults Who Have Asthma That is Not Controlled by High Dose Inhaled Corticosteroid Asthma MedicationsCompletedNCT01576718Phase 2Results posted
• Efficacy, Safety and Tolerability of Two Fixed Dose Combinations of Aclidinium Bromide/Formoterol Fumarate, Aclidinium Bromide, Formoterol Fumarate and Placebo for 28-Weeks Treatment in Patients With Moderate to Severe, Stable Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT01572792Phase 3Results posted
• A Dose-ranging Study of Fluticasone Furoate (FF)CompletedNCT01563029Phase 2Results posted
• Characterization of 24-hour Lung Function Profiles of Inhaled Tiotropium + Olodaterol Fixed Dose Combination in Patients Suffering From Chronic Obstructive Pulmonary DiseaseCompletedNCT01559116Phase 3Results posted
• Inhaled Fluticasone Effects on Upper Airway Patency in Obstructive Lung DiseaseTerminatedNCT01554488Phase 4Results posted
• A Randomised Effectiveness Study Comparing Fluticasone Furoate (FF, GW685698)/Vilanterol (VI, GW642444) With Standard Treatment in Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT01551758Phase 3Results posted
• Airway Microbiome in Asthma: Relationships to Asthma Phenotype and Inhaled Corticosteroid TreatmentCompletedNCT01537133Not applicableResults posted
• Effects of Salmeterol on Autonomic Nervous SystemCompletedNCT01536587Phase 4Results posted
• Japan Long-term Safety for Tiotropium Plus OlodaterolCompletedNCT01536262Phase 3Results posted
• Effect on Exercise Endurance and Lung Hyperinflation of Tiotropium + Olodaterol in COPD Patients.CompletedNCT01533935Phase 3Results posted
• Effect on Exercise Endurance and Lung Hyperinflation of Tiotropium + Olodaterol in COPD PatientsCompletedNCT01533922Phase 3Results posted
• Randomized Placebo-Controlled Trial of Budesonide Multi-Matrix System (MMX®) 9 Milligrams (mg) in Participants With Ulcerative Colitis Currently on a 5-Aminosalicylic Acid (5-ASA)CompletedNCT01532648Phase 3Results posted
• Preliminary Efficacy, Safety and Pharmacokinetics Study of Nepadutant in Infant With Feeding IntoleranceCompletedNCT01532518Phase 2Results posted
• The Safety Evaluation of Aminophylline and Ambrisentan When Administered Orally Alone and in Combination to Healthy VolunteersCompletedNCT01530464Phase 1Results posted
• A Study to Determine the Effect of Tiotropium + Olodaterol Fixed Dose Combination on Exercise Endurance Time During Constant Work Rate Cycle Ergometry Test in COPDCompletedNCT01525615Phase 3Results posted
• The Use of Inhaled Corticosteroids in the Treatment of Asthma is Children in the Emergency RoomCompletedNCT01524198Phase 2/3Results posted
• Effect of Flovent Discus vs QVAR vs Pulmicort Flexhaler on Short Term GrowthCompletedNCT01520688Phase 4Results posted
• Premedication Trial for Tracheal Intubation of the NEOnateCompletedNCT01490580Phase 2/3Results posted
• Study to Evaluate the Safety of Long-Term Use of Perforomist® (Formoterol Fumarate)CompletedNCT01488019Phase 4Results posted
• Role of microRNAs in T Cell-Driven Inflammation in AsthmaCompletedNCT01484691Not applicableResults posted
• Tiotropium (18mcg) in Chronic Obstructive Pulmonary Disease (COPD) Patients With a Respiratory InfectionCompletedNCT01483625Phase 4Results posted
• A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing SteroidsCompletedNCT01479621Phase 2Results posted
• SAS115359: A 6-month Study to Assess the Safety and Benefit of Inhaled Fluticasone Propionate/Salmeterol Combination Compared With Inhaled Fluticasone Propionate in the Treatment of Adolescents and Adults (12 Years of Age and Older) With Asthma.CompletedNCT01475721Phase 4Results posted

← Bronchodilator Agents overview